Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
Valuation vs Instaport thresholds (P/E, PEG, P/FCF, P/S)
Licensed market data — shown to members, not published to the open web.
Profile
From SEC filingsCompany description
Operations and Industry Our business is highly dependent on the success of our product candidate, amsoki-cel. If we are unable to successfully complete clinical development, obtain regulatory approval for or commercialize our product candidate, or if we experience delays in doing so, our business will be materially harmed. To date, as an organization, we have not completed the development of any product candidates and our current product candidate remains in clinical development. Our future success and ability to generate revenue from our product candidate is dependent on our ability to successfully develop, obtain regulatory approval for, and commercialize our product candidate or any future product candidate. Our product candidate and any future product candidates will require substantial additional investment for clinical development, regulatory review, and approval in one or more jurisdictions.
Read the full filing description · filed 28 Aug 2026
At a glance
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- CEO
- Madan Jagasia
- Employees (2026)
- 87
Sector is derived from the SEC industry classification.
1030 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, United States · (781) 806-6245 · obsidiantx.com
Source: SEC filings. Information and analytics, not investment advice.